AR078572A1 - Anticuerpos quimericos anti-cd151 y sus usos para el tratamiento del cancer - Google Patents
Anticuerpos quimericos anti-cd151 y sus usos para el tratamiento del cancerInfo
- Publication number
- AR078572A1 AR078572A1 ARP100103678A ARP100103678A AR078572A1 AR 078572 A1 AR078572 A1 AR 078572A1 AR P100103678 A ARP100103678 A AR P100103678A AR P100103678 A ARP100103678 A AR P100103678A AR 078572 A1 AR078572 A1 AR 078572A1
- Authority
- AR
- Argentina
- Prior art keywords
- antibodies
- protein
- cancer treatment
- treatment
- chemical antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente se relaciona con anticuerpos con capacidad para unirse específicamente a la proteína humana CD151, especialmente anticuerpos monoclonales de origen murino, que son quiméricos y humanizados y también con las secuencias de aminoácidos y ácidos nucleicos que codifican esos anticuerpos. Incluye además el uso de esos anticuerpos como medicamentos para el tratamiento profiláctico y/o terapéutico del cáncer y en métodos o kits de diagnostico de enfermedades asociadas a la sobreexpresion de la proteína CD151. Por ultimo incluye productos y/o composiciones que comprenden dichos anticuerpos en combinacion con anticuerpos y/o agentes anticancerosos o conjugados a toxinas y/o radioelementos y su uso en la prevencion y/o tratamiento de ciertos cánceres.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09305964A EP2308897A1 (en) | 2009-10-09 | 2009-10-09 | Chimeric antibodies specific for CD151 and use thereof in the treatment of cancer |
US26602009P | 2009-12-02 | 2009-12-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR078572A1 true AR078572A1 (es) | 2011-11-16 |
Family
ID=41682879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP100103678A AR078572A1 (es) | 2009-10-09 | 2010-10-08 | Anticuerpos quimericos anti-cd151 y sus usos para el tratamiento del cancer |
Country Status (19)
Country | Link |
---|---|
US (1) | US20120275997A1 (es) |
EP (2) | EP2308897A1 (es) |
JP (1) | JP2013507114A (es) |
KR (1) | KR20120094474A (es) |
CN (1) | CN102597004A (es) |
AR (1) | AR078572A1 (es) |
AU (1) | AU2010305360A1 (es) |
BR (1) | BR112012008266A2 (es) |
CA (1) | CA2775634A1 (es) |
IL (1) | IL219034A0 (es) |
IN (1) | IN2012DN02696A (es) |
MA (1) | MA33668B1 (es) |
MX (1) | MX2012004059A (es) |
NZ (1) | NZ599097A (es) |
RU (1) | RU2012113418A (es) |
TN (1) | TN2012000151A1 (es) |
TW (1) | TW201118168A (es) |
WO (1) | WO2011042534A1 (es) |
ZA (1) | ZA201202291B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013125221A1 (ja) * | 2012-02-21 | 2013-08-29 | 静岡県 | 抗体精製用アフィニティリガンド |
JP6386995B2 (ja) * | 2013-04-08 | 2018-09-05 | テオリアサイエンス株式会社 | 大腸がんの検出方法 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4424200A (en) | 1979-05-14 | 1984-01-03 | Nuc Med Inc. | Method for radiolabeling proteins with technetium-99m |
US4479930A (en) | 1982-07-26 | 1984-10-30 | Trustees Of The University Of Massachusetts | Amines coupled wth dicyclic dianhydrides capable of being radiolabeled product |
US4831175A (en) | 1986-09-05 | 1989-05-16 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Backbone polysubstituted chelates for forming a metal chelate-protein conjugate |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
IL162181A (en) | 1988-12-28 | 2006-04-10 | Pdl Biopharma Inc | A method of producing humanized immunoglubulin, and polynucleotides encoding the same |
GB8924581D0 (en) | 1989-11-01 | 1989-12-20 | Pa Consulting Services | Bleaching of hair |
GB9014932D0 (en) | 1990-07-05 | 1990-08-22 | Celltech Ltd | Recombinant dna product and method |
WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
JPH05244982A (ja) | 1991-12-06 | 1993-09-24 | Sumitomo Chem Co Ltd | 擬人化b−b10 |
US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
US6245898B1 (en) * | 1998-06-15 | 2001-06-12 | The Research Foundation Of State University Of New York | Monoclonal antibodies that recognize antigens associated with tumor metastasis |
UA94734C2 (ru) * | 2006-03-30 | 2011-06-10 | Глаксо Груп Лимитед | ТЕРАПЕВТИЧЕСКОЕ АНТИТЕЛО, КОТОРОЕ СВЯЗЫВАЕТСЯ С b-АМИЛОИДНЫМ ПЕПТИДОМ |
WO2008020586A1 (en) * | 2006-08-14 | 2008-02-21 | Forerunner Pharma Research Co., Ltd. | Diagnosis and treatment of cancer using anti-desmoglein-3 antibody |
GB0619291D0 (en) * | 2006-09-29 | 2006-11-08 | Ucb Sa | Altered antibodies |
FR2907341B1 (fr) * | 2006-10-18 | 2012-08-17 | Pf Medicament | Utilisation d'un anticorps anti-cd151 pour le traitement du cancer |
CL2008003561A1 (es) * | 2007-11-30 | 2010-02-05 | Glaxo Group Ltd | Construccion de union a il - 13 que comprende a lo menos un dominio simple (dab) de anticuerpo injertado en un anticuerpo monoclonal ( mabdab); polinucleotido y celula huesped; procedimiento para preparar la construccion; composicion farmaceutica que la comprende y uso para tratar cancer o enfermedades inflamatorias. |
FR2929946B1 (fr) * | 2008-04-11 | 2010-05-28 | Pf Medicament | Nouveaux anticorps anti-cd151 et leur utilisation pour le traitement du cancer |
-
2009
- 2009-10-09 EP EP09305964A patent/EP2308897A1/en not_active Withdrawn
-
2010
- 2010-10-07 TW TW099134185A patent/TW201118168A/zh unknown
- 2010-10-08 KR KR1020127009804A patent/KR20120094474A/ko not_active Application Discontinuation
- 2010-10-08 EP EP10771377A patent/EP2486057A1/en not_active Withdrawn
- 2010-10-08 CA CA2775634A patent/CA2775634A1/en not_active Abandoned
- 2010-10-08 BR BR112012008266A patent/BR112012008266A2/pt not_active IP Right Cessation
- 2010-10-08 MX MX2012004059A patent/MX2012004059A/es unknown
- 2010-10-08 AU AU2010305360A patent/AU2010305360A1/en not_active Abandoned
- 2010-10-08 NZ NZ599097A patent/NZ599097A/en not_active IP Right Cessation
- 2010-10-08 US US13/500,745 patent/US20120275997A1/en not_active Abandoned
- 2010-10-08 JP JP2012532613A patent/JP2013507114A/ja active Pending
- 2010-10-08 CN CN2010800506032A patent/CN102597004A/zh active Pending
- 2010-10-08 RU RU2012113418/10A patent/RU2012113418A/ru not_active Application Discontinuation
- 2010-10-08 AR ARP100103678A patent/AR078572A1/es unknown
- 2010-10-08 WO PCT/EP2010/065085 patent/WO2011042534A1/en active Application Filing
-
2012
- 2012-03-28 IN IN2696DEN2012 patent/IN2012DN02696A/en unknown
- 2012-03-29 ZA ZA2012/02291A patent/ZA201202291B/en unknown
- 2012-04-02 TN TNP2012000151A patent/TN2012000151A1/en unknown
- 2012-04-03 IL IL219034A patent/IL219034A0/en unknown
- 2012-04-13 MA MA34772A patent/MA33668B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
IN2012DN02696A (es) | 2015-09-04 |
NZ599097A (en) | 2014-03-28 |
BR112012008266A2 (pt) | 2019-09-24 |
JP2013507114A (ja) | 2013-03-04 |
CN102597004A (zh) | 2012-07-18 |
MA33668B1 (fr) | 2012-10-01 |
US20120275997A1 (en) | 2012-11-01 |
MX2012004059A (es) | 2012-05-22 |
WO2011042534A1 (en) | 2011-04-14 |
CA2775634A1 (en) | 2011-04-14 |
EP2308897A1 (en) | 2011-04-13 |
IL219034A0 (en) | 2012-06-28 |
TW201118168A (en) | 2011-06-01 |
AU2010305360A1 (en) | 2012-04-19 |
ZA201202291B (en) | 2012-11-28 |
TN2012000151A1 (en) | 2013-12-12 |
KR20120094474A (ko) | 2012-08-24 |
EP2486057A1 (en) | 2012-08-15 |
RU2012113418A (ru) | 2013-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR071304A1 (es) | Anticuerpos anti cd151 (proteina de membrana de la flia. de las tetraspaninas) utiles para el tratamiento de cancer | |
BR112018014615A2 (pt) | composições de anticorpo para ror1 e métodos relacionados | |
CO2019003923A2 (es) | Anticuerpos anti-steap2, conjugados anticuerpo-fármaco, y moléculas de fijación al antígeno biespecíficas que se fijan a steap2 y cd3, y usos de estos | |
AR050036A1 (es) | Anticuerpos anti - igf- ir y sus usos | |
CY1118845T1 (el) | Πρωτεϊνες συνδεσης αντιγονου υποδοχεα α il-17 | |
PE20190510A1 (es) | Anticuerpos anti-pd-l1 y usos de los mismos | |
UY35173A (es) | Proteínas de unión al antígeno bcma | |
BR112013005242A2 (pt) | novas proteínas de ligação ao antígeno | |
BR112014011331A2 (pt) | anticorpos específicos para trop-2 e seus usos | |
PE20181054A1 (es) | Anticuerpos anti-cd19 humano humanizados y metodos de utilizacion | |
CR20190346A (es) | Conjugados de fármacos y anticuerpos anti-ccr7 | |
ECSP13012436A (es) | ANTICUERPOS PEPTÍDICOS BETA AMILOIDE ANTI-N3pGlu Y USOS DE LOS MISMOS | |
CL2012000806A1 (es) | Anticuerpo anti-guanililo ciclasa c (gcc); inmunoconjugado de dicho anticuerpo; celula, vector y metodo de produccion; composicion que comprende el anticuerpo, uso del anticuerpo o composicion para preparar un medicamento para tratar cancer, particularmente del sistema gastrointestinal. | |
AR092818A1 (es) | Anticuerpo tau humanizado | |
TR201904088T4 (tr) | Anti-CGRP bileşimleri ve bunların kullanımları. | |
CO6351751A2 (es) | Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos | |
AR062268A1 (es) | Agentes ligantes direccionados dirigidos a pdgfr-alfa y sus usos | |
BRPI0518104B8 (pt) | artigo industrializado e uso de anticorpo her2 | |
BRPI1014544B8 (pt) | anticorpo anti-il-17f monoclonal totalmente humano isolado e composição farmacêutica compreendendo o mesmo | |
AR077756A1 (es) | Anticuerpos especificos para bacterias gram-positivas | |
CL2012000524A1 (es) | Anticuerpo humanizado que se une a cdcp1 humana útil en el tratamiento del cáncer; composición farmacéutica; ácido nucleico, vector de expresión y célula huésped que lo comprende; y método para producir el anticuerpo. | |
CO6571881A2 (es) | Nuevos anticuerpos anti-cxcr4 humanizados para el tratamiento del cáncer | |
AR093357A1 (es) | Proteinas de union al antigeno y su utilizacion como producto de direccionamiento para el tratamiento del cancer | |
CY1123926T1 (el) | Αντισωματα κατα της τρανσγλουταμινασης 2 | |
AR076020A1 (es) | Anticuerpos contra la proteina tweak humana y usos de los mismos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |